Scarica l'app Stockscreener
24.95
0.65%
0.295
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AMPH Giù?
Forum
Previsione
Precedente Chiudi:
$24.66
Aprire:
$24.36
Volume 24 ore:
137.03K
Relative Volume:
0.28
Capitalizzazione di mercato:
$1.16B
Reddito:
$722.68M
Utile/perdita netta:
$134.71M
Rapporto P/E:
9.3464
EPS:
2.67
Flusso di cassa netto:
$109.94M
1 W Prestazione:
+1.22%
1M Prestazione:
-6.87%
6M Prestazione:
+1.68%
1 anno Prestazione:
-50.88%
Intervallo 1D:
$24.24
$25.13
Intervallo di 1 settimana:
$23.77
$25.13
Portata 52W:
$20.39
$53.95
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Nome
Amphastar Pharmaceuticals Inc
Settore
Telefono
909-980-9484
Indirizzo
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Confronta AMPH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
24.92 | 1.15B | 722.68M | 134.71M | 109.94M | 2.67 |
|
ZTS
Zoetis Inc
|
143.18 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.41 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.225 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
448.20 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-12 | Aggiornamento | Needham | Hold → Buy |
| 2025-05-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-02-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | Iniziato | Wells Fargo | Equal Weight |
| 2024-03-05 | Iniziato | JP Morgan | Overweight |
| 2023-11-17 | Iniziato | BofA Securities | Neutral |
| 2023-07-25 | Ripresa | Jefferies | Buy |
| 2022-10-21 | Ripresa | Jefferies | Buy |
| 2022-07-29 | Iniziato | CapitalOne | Overweight |
| 2022-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | Iniziato | Northland Capital | Outperform |
| 2019-03-13 | Downgrade | Needham | Buy → Hold |
| 2019-03-13 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | Reiterato | Needham | Buy |
| 2018-03-13 | Reiterato | Needham | Buy |
| 2017-12-01 | Reiterato | Needham | Buy |
| 2017-11-09 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | Reiterato | Needham | Buy |
| 2017-03-14 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | Reiterato | Needham | Buy |
| 2016-05-10 | Reiterato | Needham | Buy |
| 2016-02-19 | Iniziato | Wells Fargo | Outperform |
| 2015-06-19 | Reiterato | Needham | Buy |
| 2015-06-03 | Iniziato | Raymond James | Strong Buy |
| 2014-07-21 | Iniziato | Needham | Buy |
Mostra tutto
Amphastar Pharmaceuticals Inc Borsa (AMPH) Ultime notizie
Will Amphastar Pharmaceuticals Inc. stock deliver shareholder valueJuly 2025 Retail & Capital Efficiency Focused Ideas - newser.com
Real time scanner hits for Amphastar Pharmaceuticals Inc. explainedWeekly Market Report & AI Forecasted Entry/Exit Points - newser.com
Why Amphastar Pharmaceuticals Inc. (29A) stock could be next leader2025 Investor Takeaways & Short-Term Trading Alerts - newser.com
Analyzing recovery setups for Amphastar Pharmaceuticals Inc. investorsJuly 2025 Price Swings & Free Expert Approved Momentum Trade Ideas - newser.com
Using Python tools to backtest Amphastar Pharmaceuticals Inc. strategiesInsider Selling & Real-Time Stock Movement Alerts - newser.com
Will Amphastar Pharmaceuticals Inc. (29A) stock outperform energy sector in 2025July 2025 Decliners & Target Return Focused Picks - newser.com
Can trapped investors hope for a rebound in Amphastar Pharmaceuticals Inc.Portfolio Update Summary & Reliable Intraday Trade Plans - newser.com
Can Amphastar Pharmaceuticals Inc. stock maintain growth trajectoryQuarterly Market Summary & Free High Accuracy Swing Entry Alerts - newser.com
Should you wait for a breakout in Amphastar Pharmaceuticals Inc.2025 Stock Rankings & Daily Entry Point Trade Alerts - newser.com
Can Amphastar Pharmaceuticals Inc. stock hit analyst price targetsProduct Launch & Fast Entry Momentum Alerts - newser.com
Key metrics from Amphastar Pharmaceuticals Inc.’s quarterly data2025 Analyst Calls & Fast Moving Market Watchlists - newser.com
Why Amphastar Pharmaceuticals Inc. stock remains resilientJuly 2025 Institutional & Real-Time Chart Pattern Alerts - newser.com
How Amphastar’s New BAQSIMI Distribution Pact in Greater China Could Impact AMPH Investors - Yahoo Finance
Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Is Amphastar Pharmaceuticals Inc. (29A) stock trading at attractive multiplesJuly 2025 Catalysts & Community Verified Swing Trade Signals - newser.com
What momentum shifts mean for Amphastar Pharmaceuticals Inc.Weekly Profit Summary & AI Optimized Trade Strategies - newser.com
Multi asset correlation models including Amphastar Pharmaceuticals Inc.Dollar Strength & Weekly Top Performers Watchlists - newser.com
Is Amphastar Pharmaceuticals Inc. (29A) stock a buy for dividend portfoliosPortfolio Return Report & Low Risk High Win Rate Picks - newser.com
United States Anaphylaxis Treatment Market 2025: Industry - openPR.com
Applying Elliott Wave Theory to Amphastar Pharmaceuticals Inc.July 2025 Earnings & Precise Buy Zone Identification - newser.com
Why Amphastar Pharmaceuticals Inc. stock attracts high net worth investorsWatch List & Safe Entry Trade Reports - Fundação Cultural do Pará
Amphastar Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
AlphaQuest LLC Acquires 17,289 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Will Amphastar Pharmaceuticals Inc. (29A) stock beat international competitionWeekly Loss Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Amphastar Pharmaceuticals Inc Azioni (AMPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
6.01%
0.85%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):